Cell Cycle Parameters as Biological Predictors of Prognosis in AML: A Review and Update of Cell Cycle Kinetics and Remission Induction/Duration in Acute Leukemia

References

• Preisler H. D., Priore R., Azarnia N., Barcos M., Raza A., Rakowsi I., Vogler R., Winton E. L., Brownman G., Goldberg J., Gottlieb A. J., Grunwald H., Rai K., Miller K., Brennan J., Chevenick P., Joyce R., Tricot G. Prediction of response of patients with acute nonlymphocytic leukemia to remission induction therapy: Use of clinical measurements. Br J Haematol 1986; 63: 625–636
   PubMed Web of Science ®Google Scholar
• Preisler H. D., Raza A. Predictors of response of acute nonlymphocytic leukemia. Cancer Invest 1986; 4(6)575–590
   PubMed Web of Science ®Google Scholar
• Cronkite E. P., Fliedner T. M., Bond V. P., Rubini J. F., Brecher G., Guastler H. Dynamics of hemopoietic proliferation in man and mice studied by H3-Thymidine incorporation into DNA. Second U.N. Conf. Peaceful Uses of Atomic Energy Geneva 1958
   Google Scholar
• Wimber D. E., Quastler H. A 14C- and 3H-Thymidine double labeling technique in the study of cell proliferation in TRADESCANTIA root tips. Experimental Cell Research 1963; 30: 8–22
   Web of Science ®Google Scholar
• Clarkson B., Ohkita B. C., Ota K., Fried J. Studies of cellular proliferation in human leukemia. I. Estimation of growth rates of leukemic and normal hematopoietic cells in two adults with acute leukemia given single injections of tritiated thymidine. J. Clin. Invest 1967; 46(4)506–529
   PubMed Web of Science ®Google Scholar
• Gavosto F., Pileri A., Gabutti V., Masera P. Non-self-maintaining kinetics of proliferating blasts in human acute leukemia. Nature 1967; 216: 188–189
   PubMed Web of Science ®Google Scholar
• Saunders E. F., Lampkin B. C., Mauer A. M. Variation of proliferative activity in leukemic cell populations of patients with acute leukemia. J. Clin. Invest 1987; 46: 1356–1363
   Web of Science ®Google Scholar
• Killman S. A., Cronkite E. P., Robertson J. S., Fledner T. M., Bond V. P. Estimation of phases of the life cycle of leukemic cells from labeling in human beings in vivo with tritiated thymidine. Lab Invest 1963; 12: 671–684
   PubMed Web of Science ®Google Scholar
• Gavosto F., Pileri A., Bachi C., Pegoraro L. Proliferation and maturation defect in acute leukemia cells. Nature 1964; 203: 93–94
   Web of Science ®Google Scholar
• Greenberg M. L., Chanana A. D., Cronkite E. P., Giacomelli G., Rai K. R., Schiffer L. M., Stryckmans P. A., Vincent P. C. The generation time of human leukemic myeloblasts. Lab Invest 1972; 26: 245–252
   PubMed Web of Science ®Google Scholar
• Gavosto F., Pileri A., Gabutti V., Masera P. Cell population kinetics in human acute leukemia. Eur. J. Cancer 1967; 3: 301–307
   PubMedGoogle Scholar
• Clarkson B., Strife A., Fried J., Sakai Y., Ota K., Ohkita T., Masuda R. Studies of cellular proliferation in human leukemia. IV. Behaviour of leukemic cells in 3 adults with acute leukemia given continuous infusions of 3H-thymidine for 8 to 10 days. Cancer 1970; 26: 1237–1260
   Web of Science ®Google Scholar
• Mauer A., Fischer V. Characteristics of cell proliferation in four patients with untreated leukemia. Blood 1966; 28: 428–445
   PubMed Web of Science ®Google Scholar
• Stryckmans P., Cronkite E. P., Fache J., Fliedner T. M., Ramos J. Deoxyribonucleic acid synthesis time of erythropoietic and granulopoietic cells in human beings. Nature 1966; 211: 717–720
   PubMed Web of Science ®Google Scholar
• Wagner H. P., Coltier H. Blast cell proliferation in a child with untreated acute leukemia: Results of a preliminary study using tritiated thymidine for pulse-labeling in vivo. Europ. J. Cancer 1967; 3: 343–348
   PubMedGoogle Scholar
• Mauer A. M., Fisher V. In vivo study of cell kinetics in acute leukemia. Nature 1963; 197: 576–576
   PubMed Web of Science ®Google Scholar
• Saunders E. F., Mauer A. M. Re-entry of nondividing leukemic cells into a proliferative phase in acute childhood leukemia. 0000
   Google Scholar
• Cronkite E. P. Leukemia revisited. Blood cells 1981; 7: 11–30
   PubMedGoogle Scholar
• Raza A., Ucar K., Preisler H. D. Double labeling and in vitro versus in vivo incorporation of bromodeoxyuridine in patients with acute nonlymphocytic leukemia. Cytometry 1985; 6: 633–640
   PubMedGoogle Scholar
• Hoshino T., Naglashima T., Murovic J. A., Wilson C. B. In situ cell kinetic studies on human neuro ectodermal tumors with bromodeoxyuridine labeling. J. Neurosurg 1986; 64: 453–60
   PubMed Web of Science ®Google Scholar
• Shibui S., Hoshino T, Vanderlaau M., Gray J. W. Double labeling with iodo- and bromodeoxyuridine for cell kinetic studies. J. Histochem. Cytochem 1989; 37: 1007–1011
   PubMed Web of Science ®Google Scholar
• Saffhill R., Hume W. J. The degradation of 5-iododeoxyuridine and 5-bromodeoxyruidine by serum from different sources and it's consequence for the use of the compounds for incorporation into DNA. Chem. Biol Interactions 1986; 57: 347–355
   PubMed Web of Science ®Google Scholar
• Mitchell J. B., Kinsella T. J., Russo A., McPherson S., Rowland J., Smith B. H., Kornblith P. L., Glatstein E. Radiosensitization of hematopoietic precursor cells (CFUc) in glioblastoma patients receiving intermittent intravenous infusions of bromodeoxyuridine (BrdU). Rad. Onc. Biol. Physics 1983; 9(4)457–463
   PubMed Web of Science ®Google Scholar
• Raza A., Maheshwari Y., Preisler H. D. Differences in cell cycle characteristics amongst patients with acute nonlymphocyctic leukemia. Blood 1987; 69(6)1647–1653, 1987
   PubMed Web of Science ®Google Scholar
• Raza A., Preisler H. D., Day R., Yasin Z., White L. M., Lykins J., Barcos M., Bennett J., Brownman G., Goldberg J., Larson R., Vogler R. Direct relationship between remission duration in acute myeloid leukemia and cell cycle kinetics. A Leukemia Intergroup Study. Blood 1990; 76(11)2191–2197
   PubMed Web of Science ®Google Scholar
• Raza A., Spiridonidis C., Ucar K., Bankert R., Mayers G., Preisler H. D. Double labeling of S-phase murine cells with bromodeoxyuridine and a second DNA specific probe. Cancer Res 1985; 45: 2283–2287
   PubMed Web of Science ®Google Scholar
• Quastler H. The analysis of cell proliferation kinetics, in Cell Proliferation, L. F. Lemerton, R. J. M. Fry. Blackwell Scientific, Oxford 1963; 18
   Google Scholar
• Hiddeman W., Buchner T., Andreef M., Wormann B., Melamed M., Clarkson B. D. Bone marrow biopsy instead of “marrow juice” for cell kinetic analysis: Comparison of bone marrow biopsy and aspiration material. Leuk. Res 1982; 6: 601–612
   PubMed Web of Science ®Google Scholar
• Hodrinet R. S. G., Van Egmond J., Wessels J. M. C., Haanen C. A method for quantification of peripheral blood admixture in bone marrow aspirates. Exp. Hematol 1980; 8: 103–107
   Web of Science ®Google Scholar
• Dosik G. M., Barlogie B., Gohde W., Johnston D., Tekell J. L., Drewinko B. Flow cytometry of DNA content in human bone marrow: A critical reappraisal. Blood 1980; 55: 734–740
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C. The French American British (FAB) Cooperative Group: Proposals for the classification of the acute leukemias. Br. J. Haematol 1976; 33: 451–458
   PubMed Web of Science ®Google Scholar
• Preisler H. D., Bjornsson S., Henderson E. S., Hyrniuk W., Higby D. Remission induction in acute non-lymphocytic leukemia: Comparison of a 7-day and 10-day infusion of cytosine arabinoside in combination with adriamycin. Med. Ped. Onc 1979; 7: 269–275
   PubMedGoogle Scholar
• Ohnuma T., Rosner F., Levy R. N., Cuttner J., Moon J. M., Silver R. T., Blom J., Falkson G., Burningham R., Glidewell O., Holland J. F. Treatment of adult leukemia with L-Asparaginase (NSC-109229). Cancer Chemo. Rep 1982; 55(3)269–275
   Google Scholar
• Preisler H. D. Treatment failure in AML. Blood Cells 1982; 8: 585–602
   PubMedGoogle Scholar
• Gezer S., Yasin A., Imren S., Raza A. Changes observed in the growth fraction labeling index, duration of S-phase and total cell cycle times of HL-60 cells as they undergo differentiation in response to retinoic acid. Cancer Res 1988; 48: 5989–5994
   PubMed Web of Science ®Google Scholar
• Preisler H. D., Raza Z., Yousuf N. The use of biologically active noncytotoxic agents to slow regrowth between course of chemotherapy. Proc. Assoc. Cancer Res 1991; 32: 2142, 361
   Google Scholar
• Miller M. A., Mazsewski C. M., Yousuf N., Sheikh Y., White L. M., Yanik G. A., Hyams D. M., Lampkin B. C., Raza A. Simultaneous immunohistochemical detection of IUdR and BrdU infused intravenously to cancer patients. Journal of Histochemistry and Cytochemistry 1991; 39: 407–412, April.
   PubMed Web of Science ®Google Scholar